Piramal Pharma Stock Surges 6% After Q3 Results Show Strong Standalone Performance Amidst Corporate Restructuring
Mumbai: In a display of classic market schizophrenia, Piramal Pharma Ltd’s (NSE: PPLPHARMA) stock shot up over 5.8% to ₹162.95 today, even as its consolidated financials bled red ink.
Read More